Low blood pressure is common in patients with heart failure and reduced ejection fraction
(HFrEF). While spontaneous hypotension predicts risk in HFrEF, there is only limited …

Electrical storm (ES) reflects life-threatening cardiac electrical instability with 3 or more
ventricular arrhythmia episodes within 24 hours. Identification of underlying arrhythmogenic …

Aims Cardiac resynchronization therapy (CRT) is an established treatment for heart failure.
There is contradictory evidence whether defibrillator capability improves prognosis in …

Члены Рабочей группы подтвердили отсутствие финансовой поддержки/конфликта
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Рабочей …

Clinicians accept that there are many unknowns when we make diagnostic and therapeutic
decisions. Acceptance of uncertainty is essential for the pursuit of the profession: bedside …

Background: Heart failure is associated with aging. It is one of the leading causes of
morbidity and mortality in Western countries and constitutes the main cause of …

Background: Prescribed dosages of heart failure (HF) therapy in patients with a reduced left
ventricular ejection fraction remain lower than guideline recommended. It remains unclear …

Hypertensive left ventricular hypertrophy (HTN LVH) is associated with almost threefold
increased risk of ventricular tachycardia (VT)/ventricular fibrillation (VF). Furthermore, HTN …

Carvedilol is an FDA-approved β-blocker commonly used for treatment of high blood
pressure, congestive heart failure, and cardiac tachyarrhythmias, including atrial fibrillation …

The remarkable scientific progress in the treatment of patients with heart failure (HF) and
reduced ejection fraction (HFrEF) has more than halved the risk of sudden cardiac death …